Motherhood After 35 or 40: What Science Allows, What Responsibility Demands
In today’s world, many women are choosing to start families later due to career, personal, or social reasons. Modern reproductive medicine, especially IVF, has made pregnancy after 35 and even 40 increasingly achievable.
But let’s be clear: science has expanded possibilities, not eliminated biological realities.
Fertility declines with age, primarily due to a reduction in egg quality and an increase in chromosomal abnormalities. While IVF and advanced techniques can help overcome some of these challenges, success rates are still closely linked to age.
At our clinic, we believe in honest, evidence-based counselling rather than unrealistic reassurance.
What You Should Know
- Pregnancy after 35 is common today and can be managed safely with proper care
- After 40, fertility declines significantly, and treatment often requires advanced strategies
- Beyond 45, chances with own eggs are extremely low, and treatment decisions must be taken very carefully
Beyond Biology: The Bigger Question
Having a child is not just about achieving pregnancy.
It is about being able to support that child physically, emotionally, and financially for decades to come. Each stage of parenting comes with different demands, and age plays a role in that journey.
As clinicians, our role is not just to help create life, but to ensure that it begins in a setting where it can be nurtured responsibly.
Legal and Ethical Boundaries
As per the Assisted Reproductive Technology (Regulation) Act, 2021, fertility treatments are permitted only up to a certain age limit.
ART procedures are not allowed for women above 50 years in India.
Our Approach
We support women who choose motherhood later in life.
But we do so with clear guidance, realistic expectations, and a strong emphasis on long-term responsibility.
Because the goal is not just pregnancy.
The goal is a healthy child and a stable, supportive life ahead.
How Age Affects Female Fertility
Female fertility is closely linked to both the number (quantity) and genetic competence (quality) of oocytes.
A woman is born with a finite pool of oocytes, estimated at around 1–2 million at birth, which declines to approximately 300,000–500,000 by puberty. Over the reproductive lifespan, only about 400–500 oocytes are ovulated, while the majority undergo atresia.
By the mid-30s, there is a marked acceleration in the decline of ovarian reserve, and by around 35 years of age, both the number and quality of remaining oocytes begin to reduce more rapidly.
However, the more critical factor is oocyte quality.
With increasing age:
- There is a higher risk of meiotic errors during chromosome segregation
- This is largely due to age-related deterioration of cohesin proteins and spindle apparatus integrity, which are essential for accurate chromosomal alignment and separation
- As a result, there is an increased incidence of aneuploidy (abnormal chromosome number)
These chromosomal abnormalities are a major cause of:
- Reduced implantation rates
- Higher miscarriage rates
- Increased risk of conditions such as Down syndrome and other aneuploidies
Fertility Decline by Age:
Age | Monthly Fertility | Natural Miscarriage |
25 | 20-25% | 12% |
30 | 15-20% | 13% |
35 | 8-12% | 17% |
40 | 3-5% | 34% |
45 | 1-2% | 45% |
IVF Success Rates for Advanced Maternal Age : Setting the Right Expectations
As age increases, natural conception declines due to reduced egg quality and increased chromosomal abnormalities. IVF can improve the chance of pregnancy per cycle by retrieving multiple eggs and creating embryos, but it does not reverse the effects of age on egg quality.
The most important determinant of success remains the availability of chromosomally normal (euploid) embryos, which declines significantly with age.
Age Group | Approx. Live Birth Rate per Cycle |
35–37 years | ~35–45% |
38–40 years | ~20–30% |
41–43 years | ~10–20% |
44–45 years | ~5–10% |
>45 years | <5% |
What PGT-A Actually Does (and What It Does Not Do)
Preimplantation genetic testing for aneuploidy (PGT-A) is often misunderstood.
What it does:
- Helps identify embryos with normal chromosome numbers
- Reduces the likelihood of transferring embryos that may lead to miscarriage
- Can reduce time to pregnancy by prioritizing embryos with higher implantation potential
What it does NOT do:
- Does not improve egg or embryo quality
- Does not increase the number of healthy embryos available
- Does not overcome age-related decline in fertility
Key Strategies for IVF Success at Advanced Age
Strategy 1: Thorough Pre-IVF Testing
Before starting IVF, a focused baseline evaluation is essential. This typically includes:
- AMH (Anti-Müllerian Hormone)
- Antral Follicle Count (AFC) on ultrasound
- Day 2–3 FSH and estradiol
- Prolactin and thyroid function tests
These tests help estimate ovarian response to stimulation and guide protocol planning.
Important: These parameters reflect how many eggs we may retrieve, not the genetic quality of those eggs.
In some cases, correctable conditions such as thyroid dysfunction or elevated prolactin may be identified and treated before starting IVF, helping optimize overall outcomes.
Strategy 2: Optimized Ovarian Stimulation
Women above 35–40 often show variable responses to ovarian stimulation. While some may have a reduced ovarian reserve and produce fewer eggs, others may still respond adequately. Treatment protocols should therefore be individualized rather than standardized. Increasing hormone doses beyond a certain point does not necessarily improve outcomes, especially in poor responders. In selected cases, alternative approaches such as mild stimulation or natural cycle IVF may be considered. Close monitoring during stimulation helps optimize response while avoiding unnecessary intervention. At this stage, the focus should remain on obtaining the best possible quality of oocytes rather than simply increasing the number retrieved.
Strategy 3: Advanced Embryo Assessment
Embryo selection is primarily based on morphological evaluation, with time-lapse imaging used in some settings to provide additional developmental information. These tools help in ranking embryos for transfer, but their ability to predict chromosomal normality is limited.
Preimplantation genetic testing (PGT-A) can be used in selected cases to identify embryos with a normal chromosome number. It may help reduce time to pregnancy by prioritizing embryos with higher implantation potential and lowering the risk of transferring aneuploid embryos.
However, it is important to note that PGT-A does not improve embryo quality or increase the number of viable embryos available. Its role should be individualized rather than routine, particularly in women of advanced maternal age where the main limitation is often the availability of euploid embryos itself.
Strategy 4: Frozen Embryo Transfer (FET)
The choice between fresh and frozen embryo transfer should be individualized rather than routine. While frozen embryo transfer (FET) can be beneficial in certain situations, it is not universally superior to fresh transfer.
In some patients, factors such as elevated progesterone levels during stimulation or suboptimal endometrial conditions may make a freeze-all approach more appropriate, allowing transfer in a subsequent, more physiologically stable cycle. However, in many cases, fresh embryo transfer remains equally effective.
The decision should be based on cycle-specific factors, not age alone.
Strategy 5: Uterine Receptivity Assessment
Endometrial receptivity plays a role in implantation, but in most women, the window of implantation is predictable and consistent. The routine use of tests such as the Endometrial Receptivity Array (ERA) is therefore not recommended for all patients.
ERA aims to identify the timing of optimal endometrial receptivity and may be considered in selected cases, particularly in women with recurrent implantation failure. However, current evidence does not support its widespread use as a first-line test, and its benefit in improving overall success rates remains limited. ERA test costs are typically between INR 20,000 to INR 30,000.
The focus should remain on appropriate case selection rather than routine testing.
Strategy 6: Lifestyle Optimization
General health plays a supportive role in IVF outcomes. Maintaining a healthy body weight, ensuring adequate sleep, managing stress, regular physical activity, and balanced nutrition are all beneficial during treatment. Correcting Vitamin D deficiency and avoiding smoking and alcohol are also important.
Certain supplements, such as CoQ10, are sometimes used in practice; however, current evidence for their impact on improving egg quality or IVF outcomes remains limited and not definitive.
Lifestyle measures help optimize overall health, but they cannot reverse age-related decline in fertility.
Cost of IVF Treatment at Advanced Age
Basic IVF (age 35-40): ₹1,75,000 – ₹2,00,000. IVF with PGT (highly recommended at 40+): ₹2,75,000 – ₹3,25,000. Additional testing (AMH, ERA, etc.): ₹15,000 – ₹30,000. Pre-treatment supplements (CoQ10, Vitamin D): ₹3,000 – ₹5,000. Frozen embryo transfer if needed: ₹35,000 – ₹60,000.
Pregnancy After Advanced Maternal Age
Once pregnancy is achieved at an advanced maternal age, certain maternal risks are higher compared to younger women. These include conditions such as gestational diabetes, hypertensive disorders of pregnancy, and a higher likelihood of obstetric interventions.
However, with appropriate antenatal care, regular monitoring, and timely management, many women are able to have good pregnancy outcomes.
It is important that such pregnancies are followed in centers with access to experienced obstetric care and, where required, maternal–fetal medicine support.
The focus should be on careful monitoring and risk management rather than assuming uniformly uncomplicated outcomes.
FAQ About IVF at Advanced Maternal Age
In India, IVF treatment is regulated under the Assisted Reproductive Technology (Regulation) Act, 2021, which sets an upper age limit. ART procedures are permitted for women up to 50 years of age.
From a clinical perspective, fertility declines significantly with age due to reduced egg quality and ovarian reserve. In many women above 43–45, the chances of success with their own eggs are low, and options such as egg donation may be discussed.
The decision is guided by both legal limits and biological factors, along with overall health and patient-specific considerations.
Preimplantation genetic testing (PGT-A) is used to assess embryos for chromosomal abnormalities before transfer. As maternal age increases, the proportion of embryos with chromosomal abnormalities also rises, which can contribute to failed implantation or miscarriage.
PGT-A can help in selecting embryos with a normal chromosome number, and in some cases may reduce time to pregnancy by avoiding transfer of embryos that are unlikely to implant.
However, it is important to understand that:
- PGT-A does not improve embryo quality
- It does not increase the number of healthy embryos available
- It does not guarantee success
At our clinic, PGT-A is not used routinely, but considered selectively based on individual clinical situations.
The goal is better selection, not overuse of testing.
Not at all. AMH reflects ovarian reserve (egg quantity), not egg quality. Women with low AMH may produce fewer eggs, but pregnancy is still possible, especially with appropriate planning and realistic expectations.
In such cases, treatment is tailored to optimize the response from the available ovarian reserve. However, it is important to understand that outcomes depend on multiple factors, including age.
For women with very low reserve or repeated unsuccessful attempts, options such as egg donation may also be discussed.
Low AMH indicates fewer opportunities, not zero chances.
Age is an important factor, but it is not the only consideration. A proper assessment includes overall health, including cardiovascular and metabolic status, as well as obstetric risk factors.
While some women at a higher age may be medically fit to carry a pregnancy, it is important to recognize that pregnancy-related risks do increase with age, and require closer monitoring.
In India, treatment is also guided by legal limits under the Assisted Reproductive Technology (Regulation) Act, 2021, which permits ART procedures up to 50 years of age.
The decision should balance medical fitness, age-related risks, and realistic expectations, rather than relying on age alone.
This depends on your ovarian reserve, age, and how you respond to stimulation.
If ovarian reserve is low, a single cycle may yield only a few embryos. In such situations, multiple cycles may be planned to accumulate embryos over time, a strategy often referred to as embryo pooling.
Embryo pooling involves performing more than one stimulation cycle and freezing embryos from each cycle before attempting transfer. This can:
- Increase the total number of embryos available for selection
- Improve the likelihood of identifying a viable embryo for transfer
- Be particularly useful in women with reduced ovarian reserve
Additionally, for couples who wish to have more than one child in the future, creating and freezing multiple embryos earlier can be beneficial. This helps preserve embryos at a younger biological age, rather than relying on ovarian response at a later stage.
In women with a good ovarian response and multiple embryos in a single cycle, further cycles may not be necessary.
The decision to pursue additional cycles should be individualized, balancing expected benefit, cost, and long-term family planning goals.
The risk of chromosomal abnormalities increases with maternal age, primarily due to higher rates of errors during egg division. This can increase the chances of conditions such as Down syndrome and other aneuploidies.
Preimplantation genetic testing (PGT-A) can help in identifying embryos with normal chromosome numbers before transfer and may reduce the risk of transferring embryos with known chromosomal abnormalities. However, it is important to understand that:
- PGT-A is a screening tool, not a guarantee
- It does not eliminate all genetic or developmental risks
In addition, pregnancies at advanced maternal age are associated with a slightly higher risk of non-genetic complications, which are typically managed with appropriate antenatal care and monitoring.
With careful evaluation, appropriate counselling, and good prenatal care, many women go on to have healthy pregnancies and babies.
This decision depends on multiple factors, including age, ovarian reserve (AMH), previous treatment response, and personal preferences.
If ovarian reserve is reasonable and eggs are being retrieved, many couples may choose to attempt IVF with their own eggs initially. However, it is important to understand that success rates decline with age, primarily due to reduced egg quality.
In situations where ovarian reserve is very low, or after repeated unsuccessful cycles, egg donation may be considered. Egg donation typically offers higher and more consistent success rates, as it uses eggs from younger donors.
An important part of this decision is also how much time, emotional energy, and financial resources a couple is willing to invest. Multiple attempts with own eggs may be reasonable for some, while others may prefer to move earlier to options with higher success rates.
The approach should be individualized, balancing biological reality with personal priorities and long-term goals
Age-related decline in fertility is progressive, and the rate of decline becomes more pronounced after the mid-30s. For this reason, unnecessary delays should be avoided.
At the same time, starting IVF without appropriate evaluation is not advisable. A brief period for proper assessment, counselling, and planning helps in optimizing the approach for each individual.
If you have been trying without success, it is reasonable to begin consultation and baseline testing without delay. In most cases, once evaluation is complete, treatment can be initiated in a timely and structured manner.
The goal is to act promptly, but with a well-planned and individualized approach.
Age alone should not be seen as an absolute barrier to motherhood, but it remains an important factor that influences outcomes. Modern IVF has expanded the possibilities for women choosing to conceive later, though success still depends largely on individual biology. At our Indore infertility clinic, we focus on honest counselling, individualized planning, and evidence-based treatment to help you make informed decisions. If you are considering pregnancy at an advanced age, a timely evaluation can help clarify your options and the best way forward..